Exicure (XCUR) traded down -7.08 % during a 24 hours period ending at 12:14 AM Central Europe on Tuesday 27th. One Exicure stock can currently be bought for about USD 1.09 on popular exchanges. Current supply of Exicure stocks is 6.5 mn. Exicure has a current market capitalization of USD 6.9 mn and approximately USD 64.3 k worth of Exicure was traded on exchanges in the last 24 hours. Since last month end, Exicure has traded -14.63 % down. Simple moving average of last 200 days is at USD 2.84. The highest price of past 52 weeks was recorded at USD 9.48 on 12/09/2025. 52 weeks low was at USD 0.94 on 10/09/2026.

Here is how related stocks have performed in the past 24 hours:

  • Vistagen Therapeutics (VTGN) traded down -5.26 % and now trades at USD 0.17. Current market capitalisation for Vistagen Therapeutics is USD 8 mn.

  • Comprehensive Healthcare Sys (CMHSF) traded flat 0 % and now trades at USD 0.25. Comprehensive Healthcare Sys has a market capitalisation of USD 8.1 mn.

  • Natural Alternatives (NAII) traded up 0.83 % and now trades at USD 1.15. Current market capitalisation for Natural Alternatives is USD 7.6 mn.

  • Lantern Pharma (LTRN) traded down -0.94 % and now trades at USD 0.61. Lantern Pharma has a market capitalisation of USD 8.1 mn.

  • Soligenix (SNGX) traded up 2.78 % and now trades at USD 0.35. Soligenix has a market capitalisation of USD 7.9 mn.


About Exicure

Exicure, Inc. is a clinical-stage biotechnology company based in Skokie, United States, which specializes in developing a new class of immunomodulatory and gene-regulating drugs against validated targets. They also address health issues such as oncology, immunology, and dermatology. Exicure serves customers in the United States and trades on the Nasdaq stock exchange.